Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9WPB

Crystal structure of human transthyretin (TTR) with pryazole-based stabilizer

これはPDB形式変換不可エントリーです。
9WPB の概要
エントリーDOI10.2210/pdb9wpb/pdb
分子名称Transthyretin, 4-[2-[3,5-bis(chloranyl)-1~{H}-pyrazol-4-yl]ethyl]benzoic acid (3 entities in total)
機能のキーワードtransthyretin, hydroxyisourate hydrolase, kinetic stabilizer, transport protein
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数8
化学式量合計113970.55
構造登録者
Choe, J.,Choi, S.,Shin, H.-C. (登録日: 2025-09-08, 公開日: 2026-05-06)
主引用文献Kim, K.A.,Lee, C.,Lim, N.,Kim, K.W.,Lee, Y.H.,Choe, J.,Kim, S.J.,Jeong, J.W.,Jeon, E.H.,Son, D.H.,Park, S.J.,Kang, N.S.,Shin, H.C.,Koo, T.S.,Choi, S.
Pyrazole-Based Transthyretin Kinetic Stabilizers Identified Using a Covalent Fluorescent Probe Assay for Selectivity Profiling in Human Serum.
J.Med.Chem., 68:26448-26465, 2025
Cited by
PubMed Abstract: Transthyretin (TTR) amyloidosis arises from the extracellular aggregation of misfolded TTR monomers into β-sheet-rich fibrils, leading to progressive tissue damage. To inhibit this process, we designed and synthesized pyrazole-based kinetic stabilizers targeting the thyroxine-binding sites of TTR. Structure-activity relationship studies revealed that derivatives with hydrophobic trans-alkene linkers and 3,5-substituted pyrazole rings showed enhanced stabilizing potency, particularly those bearing carboxylic acid, amide, or sulfonamide groups. A covalent fluorescent probe derived from trans-styrylpyrazole was developed to selectively react with Lys15, enabling fluorescence probe exclusion and native PAGE assays to evaluate stabilizer selectivity in human serum. Among these, 3,5-dichloropyrazole derivatives exhibited efficacy comparable to that of tafamidis and acoramidis. X-ray crystallography of the TTR- complex confirmed hydrogen bonding with Ser117/117' and electrostatic interactions with Lys15. Pharmacokinetic studies of compounds and demonstrated favorable exposure, bioavailability, and metabolic stability, supporting their preclinical development for hereditary- and wild-type TTR amyloidosis.
PubMed: 41362238
DOI: 10.1021/acs.jmedchem.5c02576
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.58 Å)
構造検証レポート
Validation report summary of 9wpb
検証レポート(詳細版)ダウンロードをダウンロード

257629

件を2026-08-05に公開中

PDB statisticsPDBj update infoContact PDBjnumon